TAT-RasGAP317鈥?26

General Information


DRACP ID  DRACP03659

Peptide Name   TAT-RasGAP317鈥?26

Sequence  GrkkrrqrrrGGwmwvtnlrtd

Sequence Length  22

UniProt ID  P20936  L0HA15 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  Mix



Physicochemical Information


Formula  C6H-27N3O-15

Absent amino acids  ACDEFHIKLMNPQRSTVWY

Common amino acids  G

Mass  22161

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  0

Net charge  0

Boman Index  282

Hydrophobicity  -5.45

Aliphatic Index  0

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33852935

Title  The antimicrobial peptide TAT-RasGAP 317-326 inhibits the formation and expansion of bacterial biofilms in vitro

Doi Not available

Year  2021

Literature 2

Pubmed ID 27602963

Title  The TAT-RasGAP317-326 anti-cancer peptide can kill in a caspase-, apoptosis-, and necroptosis-independent manner

Doi Not available

Year  2016

Literature 3

Pubmed ID 28638371

Title  The Anticancer Peptide TAT-RasGAP317-326 Exerts Broad Antimicrobial Activity

Doi Not available

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  10519

DRACP is developed by Dr.Zheng's team.